http://m.medicalxpress.com/news/2016-11-drug-therapy-chronic-kidney-disease.html
"Associate Professor Kevin Pfleger, is also Chief Scientific Advisor of biotechnology company Dimerix that is on track to release early results in the coming months from Phase II clinical trials of its flagship drug therapy DMX-200."
- Forums
- ASX - By Stock
- DXB
- Soon to be released...
Soon to be released..., page-3
-
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
0.025(5.62%) |
Mkt cap ! $261.8M |
Open | High | Low | Value | Volume |
45.5¢ | 49.5¢ | 45.0¢ | $2.042M | 4.280M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 98853 | 47.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 98853 | 0.470 |
2 | 35907 | 0.465 |
9 | 113359 | 0.460 |
3 | 53000 | 0.455 |
7 | 160404 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 187241 | 5 |
0.485 | 81606 | 2 |
0.490 | 76700 | 3 |
0.495 | 239400 | 9 |
0.500 | 190585 | 9 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online